Limitations of rapid serological testing for SARS-CoV-2 in non-vaccinated patients in acute cardiac care
Srpski medicinski casopis Lekarske komore · 2021
DOI: 10.5937/smclk2-32938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Srpski medicinski casopis Lekarske komore, 2021. Verfasst von Mihajlo Viduljević und 3 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
In December 2019 in the city of Wuhan, in China, the first cases of infection caused by the new SARS-CoV-2 virus appeared, and later on, the disease caused by this virus was named COVID-19. Shortly after this, on March 11 th , 2020, the WHO characterized COVID-19 as a global pandemic. The symptoms of COVID-19 and acute cardiovascular disorders (e.g., heart failure, pulmonary embolism or myocardial ischemia) frequently overlap, which poses a challenge for the establishing of a differential diagnosis in clinical practice. Rapid serological tests, which detect IgM and IgG classes of antibodies for SARS-CoV 2, have been developed with the primary purpose of screening the population's immunological response to the SARS-CoV-2 virus. However, rapid serological tests are often used outside their original purpose, i.e., for the triage of possibly infected, non-vaccinated individuals, because they offer quick results, which may be particularly relevant in emergency settings. If serological testing is used to guide the admission of non-vaccinated patients with acute cardiovascular disorders to either an isolation unit for suspected COVID-19 positive individuals, or to hospital facilities for non-infected patients, it is important to recognize its limitations, in order to reduce the risk of false-positive or false-negative results. Hence, appropriate patient selection and cautious test interpretation is necessary to avoid misdiagnosis. The aim of this paper is to illustrate how serological testing may be used as a screening tool to inform the management of non-vaccinated patients with acute cardiovascular disorders requiring urgent hospital admission. As an illustration, we describe two clinical situations, in which serological testing produced meaningful results.
Zitieren
APA
Viduljević, M., Polovina, M., Ašanin, M., & Mrdović, I. (2021). Limitations of rapid serological testing for SARS-CoV-2 in non-vaccinated patients in acute cardiac care. Srpski medicinski casopis Lekarske komore. https://doi.org/10.5937/smclk2-32938
Vancouver
Viduljević M, Polovina M, Ašanin M, Mrdović I. Limitations of rapid serological testing for SARS-CoV-2 in non-vaccinated patients in acute cardiac care. Srpski medicinski casopis Lekarske komore. 2021. doi:10.5937/smclk2-32938
BibTeX
@article{Viduljevi2021,
author = {Viduljević, Mihajlo and Polovina, Marija and Ašanin, Milika and Mrdović, Igor},
title = {Limitations of rapid serological testing for SARS-CoV-2 in non-vaccinated patients in acute cardiac care},
journal = {Srpski medicinski casopis Lekarske komore},
year = {2021},
doi = {10.5937/smclk2-32938}
}
EUVIMED